Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX4MTO
|
||||
Drug Name |
4-[(4-Chlorophenyl)methyl]-2-{1-[(4-{[3-(hexahydro-1H-azepin-1-yl)propyl]oxy}phenyl)methyl]hexahydro-1H-azepin-4-yl}-1(2H)-phthalazinone
|
||||
Synonyms |
CHEMBL1767159
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C37H45ClN4O2
|
||||
Canonical SMILES |
Clc1ccc(CC2=NN(C3CCCN(Cc4ccc(OCCCN5CCCCCC5)cc4)CC3)C(=O)c6ccccc26)cc1
|
||||
InChI |
InChI=1S/C37H45ClN4O2/c38-31-16-12-29(13-17-31)27-36-34-10-3-4-11-35(34)37(43)42(39-36)32-9-7-23-41(25-20-32)28-30-14-18-33(19-15-30)44-26-8-24-40-21-5-1-2-6-22-40/h3-4,10-19,32H,1-2,5-9,20-28H2
|
||||
InChIKey |
QYAXGGUCDQSHIT-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Alpha-1 adrenergic receptor | Target Info | [1587926] | ||
Histamine H1 receptor | Target Info | [1587926] | |||
PANTHER Pathway | Histamine H1 receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.